Insider Trading & Ownership - Koppel Adam

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Koppel Adam
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-10-16
Purchase
2023-10-18
4:30 pm
Cerevel Therapeutics Holdings Inc.CEREKoppel Adam
Director
10% Owner
5,480,052$22.81$124,999,98665,683,063
(Indirect
Direct)
View
2021-08-10
Sale
2021-08-12
8:38 pm
SpringWorks Therapeutics Inc.SWTXBain Capital Life Sciences Investors LLC
BC SW LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
1,000,000$70.25$70,250,0004,832,413
(Indirect
Direct)
View
2021-07-19
Purchase
2021-07-21
4:40 pm
RAPID MICRO BIOSYSTEMS INC.RPIDBain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
100,000$20$2,000,0008,434,560
(Indirect)
View
2021-03-09
Sale
2021-03-11
4:30 pm
SpringWorks Therapeutics Inc.SWTXBain Capital Life Sciences Investors LLC
BC SW LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
1,450,000$71.5$103,675,0005,831,307
(Indirect)
View
2020-12-10
Sale
2020-12-14
5:35 pm
Dicerna Pharmaceuticals IncDRNAKoppel Adam
Director
1,000,000$23.4$23,400,0003,080,237
(Indirect)
View
2020-11-09
Purchase
2020-11-12
5:54 pm
Cerevel Therapeutics Holdings Inc.CEREKoppel Adam
Director
10% Owner
332,293$10.3$3,422,61860,632,356
(Indirect)
View
2020-10-27
Purchase
2020-10-29
8:00 pm
Cerevel Therapeutics Holdings Inc.CEREKoppel Adam
Director
10% Owner
10,000,000$10$100,000,000110,262,006
(Indirect)
View
2020-10-26
Purchase
2020-10-27
5:07 pm
Aptinyx Inc.APTXBain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
3,333,333$3$9,999,9998,891,758
(Indirect)
View
2020-07-28
Purchase
2020-07-28
4:45 pm
Annexon Inc.ANNXBain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Koppel Adam
Bain Capital Life Sciences Partners LP
Schwartz Jeffrey Lawrence
10% Owner
400,000$17$6,800,0003,241,628
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-11
Option Award
2024-01-12
4:56 pm
N/A
N/A
Solid Biosciences Inc.SLDBKoppel Adam
Director
10% Owner
904,160$5.534,034,582
(Indirect)
View
2023-06-21
Option Award
2023-06-22
8:12 pm
2024-06-21
2033-06-20
Foghorn Therapeutics Inc.FHTXKoppel Adam
Director
16,000$016,000
(Direct)
View
2023-06-07
Other
2023-06-09
5:07 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc.CEREKoppel Adam
Director
10% Owner
432,627$060,649,418
(Indirect)
View
2023-06-07
Option Award
2023-06-09
5:07 pm
N/A
2033-06-07
Cerevel Therapeutics Holdings Inc.CEREKoppel Adam
Director
10% Owner
17,062$060,649,418
(Direct)
View
2023-06-06
Option Award
2023-06-08
5:01 pm
N/A
2033-06-06
Solid Biosciences Inc.SLDBKoppel Adam
Director
10% Owner
9,650$09,650
(Direct)
View
2022-12-13
Option Award
2022-12-15
6:19 pm
N/A
2032-12-13
Solid Biosciences Inc.SLDBKoppel Adam
Director
10% Owner
9,650$09,650
(Direct)
View
2022-12-02
Option Award
2022-12-05
5:16 pm
N/A
2032-12-01
Solid Biosciences Inc.SLDBKoppel Adam
Director
10% Owner
2,666$02,666
(Direct)
View

Ownership
2022-12-05
4:58 pm
N/A
N/A
Solid Biosciences Inc.SLDBKoppel Adam
Director
10% Owner
0$03,130,423
(Indirect)
View
2022-06-21
Option Award
2022-06-22
8:59 pm
2023-06-21
2032-06-20
Foghorn Therapeutics Inc.FHTXKoppel Adam
Director
16,000$016,000
(Direct)
View
2022-06-14
Option Award
2022-06-16
5:10 pm
N/A
2032-06-14
Cerevel Therapeutics Holdings Inc.CEREKoppel Adam
Director
10% Owner
23,459$023,459
(Direct)
View
2022-05-26
Option Award
2022-05-31
5:06 pm
N/A
2032-05-25
Aptinyx Inc.APTXKoppel Adam
Director
10% Owner
40,000$040,000
(Direct)
View
2021-12-28
Equity Swap
2021-12-29
4:43 pm
N/A
N/A
Dicerna Pharmaceuticals IncDRNAKoppel Adam
Director
3,083,570$38.250
(Direct)
View
2021-12-28
Disposition
2021-12-29
4:43 pm
N/A
N/A
Dicerna Pharmaceuticals IncDRNAKoppel Adam
Director
133,333$00
(Direct)
View
2021-07-19
Conversion
2021-07-21
4:40 pm
N/A
N/A
RAPID MICRO BIOSYSTEMS INC.RPIDBain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
50,007,380$08,434,560
(Indirect)
View

Ownership
2021-07-14
8:02 pm
N/A
N/A
RAPID MICRO BIOSYSTEMS INC.RPIDBain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Schwartz Jeffrey Lawrence
Koppel Adam
10% Owner
0$08,334,560
(Indirect)
View
2021-07-13
Option Award
2021-07-14
4:53 pm
2022-07-13
2031-07-12
Foghorn Therapeutics Inc.FHTXKoppel Adam
Director
12,530$012,530
(Direct)
View
2021-06-16
Option Award
2021-06-21
5:15 pm
N/A
2031-06-16
Solid Biosciences Inc.SLDBKoppel Adam
Director
30,000$030,000
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:25 pm
N/A
2031-06-10
Cerevel Therapeutics Holdings Inc.CEREKoppel Adam
Director
10% Owner
42,950$042,950
(Direct)
View
2021-06-03
Exercise
2021-06-07
6:50 pm
N/A
N/A
Dicerna Pharmaceuticals IncDRNAKoppel Adam
Director
3,333$03,101,903
(Direct)
View
2021-06-03
Option Award
2021-06-07
6:50 pm
N/A
N/A
Dicerna Pharmaceuticals IncDRNAKoppel Adam
Director
18,333$03,101,903
(Direct)
View
2021-05-27
Option Award
2021-06-01
4:30 pm
N/A
2031-05-26
Aptinyx Inc.APTXKoppel Adam
Director
10% Owner
40,000$040,000
(Direct)
View
2021-03-23
Option Award
2021-03-25
4:30 pm
N/A
N/A
Solid Biosciences Inc.SLDBKoppel Adam
Director
869,565$5.757,929,918
(Indirect)
View
2020-12-31
Option Award
2021-01-05
4:44 pm
N/A
2030-12-30
Aptinyx Inc.APTXKoppel Adam
Director
10% Owner
5,508$2.2245,508
(Direct)
View
2020-12-10
Option Award
2020-12-11
4:30 pm
N/A
N/A
Solid Biosciences Inc.SLDBKoppel Adam
Director
3,189,189$3.77,060,353
(Indirect)
View
2020-10-27
Other
2020-10-29
8:00 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc.CEREKoppel Adam
Director
10% Owner
49,961,943$0110,262,006
(Indirect)
View

Ownership
2020-10-29
7:45 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc.CEREKoppel Adam
Director
0$0338,120
(Indirect)
View
2020-10-26
Option Award
2020-10-26
4:30 pm
N/A
N/A
BCLS Acquisition Corp.BLSAKoppel Adam
Director
10% Owner
487,500$10487,500
(Indirect)
View

Ownership
2020-10-22
9:03 pm
N/A
2028-01-30
Foghorn Therapeutics Inc.FHTXKoppel Adam
Director
0$094,594
(Direct)
View

Ownership
2020-10-21
8:05 pm
N/A
N/A
BCLS Acquisition Corp.BLSAKoppel Adam
Director
10% Owner
0$03,503,750
(Indirect)
View
2020-09-30
Option Award
2020-10-02
4:15 pm
N/A
2030-09-29
Aptinyx Inc.APTXKoppel Adam
Director
10% Owner
5,663$2.1635,663
(Direct)
View
2020-07-28
Conversion
2020-07-28
4:45 pm
N/A
N/A
Annexon Inc.ANNXBain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Koppel Adam
Bain Capital Life Sciences Partners LP
Schwartz Jeffrey Lawrence
10% Owner
27,876,392$03,241,628
(Indirect)
View

Ownership
2020-07-23
5:06 pm
N/A
N/A
Annexon Inc.ANNXBain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Partners LP
Bain Capital Life Sciences Fund L.P.
BCIP Life Sciences Associates LP
Koppel Adam
Schwartz Jeffrey Lawrence
10% Owner
0$025,034,764
(Indirect)
View
2020-06-30
Option Award
2020-07-02
4:06 pm
N/A
2030-06-29
Aptinyx Inc.APTXKoppel Adam
Director
10% Owner
4,370$2.6774,370
(Direct)
View
2020-06-16
Option Award
2020-06-18
5:00 pm
N/A
2030-06-16
Solid Biosciences Inc.SLDBKoppel Adam
Director
40,000$040,000
(Direct)
View
2020-06-15
Option Award
2020-06-16
8:09 pm
N/A
N/A
Dicerna Pharmaceuticals IncDRNAKoppel Adam
Director
18,333$018,333
(Direct)
View
2020-05-20
Option Award
2020-05-22
4:15 pm
N/A
2030-05-19
Aptinyx Inc.APTXKoppel Adam
Director
10% Owner
40,000$040,000
(Direct)
View
2020-03-31
Option Award
2020-04-02
4:58 pm
N/A
2030-03-30
Aptinyx Inc.APTXKoppel Adam
Director
10% Owner
8,296$1.3568,296
(Direct)
View
Goto 0, 1, Next